CLCR Call: April 6, 2020

For Public Health

At a glance

The April 6, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on serology tests, answers to submitted questions, CLIA guidance, hospital systems during the COVID-19 response, Nebraska's public health laboratory response, reporting testing data to CDC, and biosafety.

Format: MP3
Language: English (US)
Size: 49 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome and Introductions: Jasmine Chaitram, CDC Division of Laboratory Systems

Performance Evaluation of Commercially Developed Serology Tests: Michele Owen, CDC Laboratory Task Force

Updates and Responses to Submitted Questions on Diagnostics and Testing: Tim Stenzel, U.S. Food and Drug Administration (FDA)

Additional CLIA Guidance for Testing Laboratories: Karen Dyer, Centers for Medicare & Medicaid Services (CMS)

COVID-19 Response – Hospital System on the Front Lines: James (Jim) Crawford, Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellHealth, Lake Success, New York

Nebraska's Public Health Laboratory Response: Peter Iwen, Nebraska State Public Health Laboratory

Reporting Testing Data to CDC: Jasmine Chaitram, CDC Division of Laboratory Systems

Laboratory Biosafety Update for COVID-19: Bill Arndt, CDC Division of Laboratory Systems

Meeting materials

Content Source
About this page
Published: November 20, 2024
Updated: April 6, 2020

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: April 6, 2020

The information on this page was last reviewed by subject matter experts to ensure accuracy.